loadpatents
name:-0.021868944168091
name:-0.011068820953369
name:-0.00041794776916504
Gailunas; Andrea Patent Filings

Gailunas; Andrea

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gailunas; Andrea.The latest application filed is for "n-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds".

Company Profile
0.12.18
  • Gailunas; Andrea - Burlingame CA
  • Gailunas; Andrea - San Francisco CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
Grant 7,727,997 - John , et al. June 1, 2
2010-06-01
N-(3-amino-2-hydroxy-propyl) Substituted Alkylamide Compounds
App 20100048590 - Gailunas; Andrea ;   et al.
2010-02-25
N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds
Grant 7,589,094 - Gailunas , et al. September 15, 2
2009-09-15
Compounds to treat Alzheimer's disease
Grant 7,553,831 - Beck , et al. June 30, 2
2009-06-30
Methods to Treat Alzheimer's Disease
App 20080058336 - Hom; Roy ;   et al.
2008-03-06
Dipeptide inhibitors of .beta.-secretase
Grant 7,276,484 - John , et al. October 2, 2
2007-10-02
Compounds to treat Alzheimer's disease
App 20070213407 - Fang; Lawrence Y. ;   et al.
2007-09-13
N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
App 20070213316 - John; Varghese ;   et al.
2007-09-13
Compounds to treat Alzheimer's disease
Grant 7,214,715 - Beck , et al. May 8, 2
2007-05-08
N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
Grant 7,176,242 - John , et al. February 13, 2
2007-02-13
Compounds to treat alzheimer's disease
App 20060287306 - Hom; Roy ;   et al.
2006-12-21
Compounds to treat Alzheimer's disease
App 20060276642 - Hom; Roy ;   et al.
2006-12-07
Methods to treat alzheimer's disease
Grant 7,119,085 - Hom , et al. October 10, 2
2006-10-10
N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds
App 20060194817 - Gailunas; Andrea ;   et al.
2006-08-31
Substituted amines for the treatment of alzheimer's disease
App 20060100196 - Gailunas; Andrea ;   et al.
2006-05-11
Compounds to treat Alzheimer's disease
Grant 7,030,239 - Hom , et al. April 18, 2
2006-04-18
Compounds to treat Alzheimer's disease
Grant 6,992,081 - Hom , et al. January 31, 2
2006-01-31
Compounds to treat Alzheimer's disease
App 20050203096 - Beck, James P. ;   et al.
2005-09-15
Dipeptide inhibitors of beta-secretase
App 20050182138 - John, Varghese ;   et al.
2005-08-18
Dipeptide inhibitors of .beta.-secretase
Grant 6,864,240 - John , et al. March 8, 2
2005-03-08
Compounds to treat alzheimer's disease
Grant 6,846,813 - Beck , et al. January 25, 2
2005-01-25
Compounds to treat Alzheimer's disease
App 20040214846 - Hom, Roy ;   et al.
2004-10-28
N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
App 20040171881 - John, Varghese ;   et al.
2004-09-02
Compounds to treat Alzheimer's disease
Grant 6,737,420 - Hom , et al. May 18, 2
2004-05-18
N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
App 20030109559 - Gailunas, Andrea ;   et al.
2003-06-12
Compounds to treat Alzheimer's disease
App 20030013881 - Hom, Roy ;   et al.
2003-01-16
Compounds to treat alzheimer's disease
App 20020143177 - Beck, James P. ;   et al.
2002-10-03
Compounds to treat alzheimer's disease
App 20020128255 - Beck, James P. ;   et al.
2002-09-12
Compounds to treat alzheimer's disease
App 20020022623 - Hom, Roy ;   et al.
2002-02-21
Methods to treat alzheimer's disease
App 20020019403 - Hom, Roy ;   et al.
2002-02-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed